Published: April 30, 2020
Exclusive: St Vincent’s in Sydney is the only confirmed location so far, as NSW Health negotiates with US pharmaceutical giant Gilead
The US pharmaceutical company Gilead is finalising the location of five hospitals in Australia to receive the highly sought-after experimental Covid-19 drug remdesivir.
The only confirmed location is St Vincent’s hospital in Sydney, a major tertiary hospital and the centre of many of the New South Wales outbreak areas. A NSW Health spokeswoman confirmed the health department “has been engaging with Gilead on gaining access to the drug for Covid-19 patients”.
Continue reading...from The Guardian https://ift.tt/35m14pp
via
0 Comments